Aaron J. Kosar

Array ( [id] => 9008943 [patent_doc_number] => 08524236 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Methods of antagonizing the binding of CD40 to CD40L with CD40L-specific monovalent polypeptides in autoimmune individuals' [patent_app_type] => utility [patent_app_number] => 11/663247 [patent_app_country] => US [patent_app_date] => 2005-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 13 [patent_no_of_words] => 90052 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11663247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4561022 [patent_doc_number] => 07846442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Methods of treating rheumatoid arthritis with an anti-TNF-alpha antibodies and methotrexate' [patent_app_type] => utility [patent_app_number] => 11/225631 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 26 [patent_no_of_words] => 17573 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/846/07846442.pdf [firstpage_image] =>[orig_patent_app_number] => 11225631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552735 [patent_doc_number] => 20090286721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'TARGETED PLASMINOGEN ACTIVATOR FUSION PROTEINS AS THROMOBOLYTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 11/817454 [patent_app_country] => US [patent_app_date] => 2005-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20866 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286721.pdf [firstpage_image] =>[orig_patent_app_number] => 11817454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829402 [patent_doc_number] => 20060063921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Ligand' [patent_app_type] => utility [patent_app_number] => 11/217919 [patent_app_country] => US [patent_app_date] => 2005-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 48624 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063921.pdf [firstpage_image] =>[orig_patent_app_number] => 11217919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 270208 [patent_doc_number] => 07563442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Antibodies to CD40 and methods of treating cancer and enhancing immune responses' [patent_app_type] => utility [patent_app_number] => 11/213575 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 34 [patent_no_of_words] => 41843 [patent_no_of_claims] => 133 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563442.pdf [firstpage_image] =>[orig_patent_app_number] => 11213575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 899246 [patent_doc_number] => 07338660 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-04 [patent_title] => 'Methods of treating cancer and enhancing immune responses with antibodies that bind CD40' [patent_app_type] => utility [patent_app_number] => 11/211917 [patent_app_country] => US [patent_app_date] => 2005-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 32 [patent_no_of_words] => 41829 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/338/07338660.pdf [firstpage_image] =>[orig_patent_app_number] => 11211917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5409515 [patent_doc_number] => 20090123413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'USE OF BAT MONOCLONAL ANTIBODY FOR IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 11/721307 [patent_app_country] => US [patent_app_date] => 2005-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9739 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123413.pdf [firstpage_image] =>[orig_patent_app_number] => 11721307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5296000 [patent_doc_number] => 20090010926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Extended Treatment of Multiple Sclerosis' [patent_app_type] => utility [patent_app_number] => 11/573823 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11802 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20090010926.pdf [firstpage_image] =>[orig_patent_app_number] => 11573823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886396 [patent_doc_number] => 20080260728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Treatment of Severe Multiple Sclerosis' [patent_app_type] => utility [patent_app_number] => 11/573817 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11183 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260728.pdf [firstpage_image] =>[orig_patent_app_number] => 11573817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5165271 [patent_doc_number] => 20070286855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-13 [patent_title] => 'IMPROVING TREATMENTS' [patent_app_type] => utility [patent_app_number] => 11/573165 [patent_app_country] => US [patent_app_date] => 2005-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5313 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20070286855.pdf [firstpage_image] =>[orig_patent_app_number] => 11573165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 823157 [patent_doc_number] => 07404955 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-29 [patent_title] => 'Methods of inhibiting or neutralizing TNFα in patients with tissue injury' [patent_app_type] => utility [patent_app_number] => 11/195589 [patent_app_country] => US [patent_app_date] => 2005-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 49 [patent_no_of_words] => 52111 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/404/07404955.pdf [firstpage_image] =>[orig_patent_app_number] => 11195589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367122 [patent_doc_number] => 20090304681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Methods for the treatment and prevention of infection using anti-selectin agents' [patent_app_type] => utility [patent_app_number] => 11/658748 [patent_app_country] => US [patent_app_date] => 2005-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13358 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304681.pdf [firstpage_image] =>[orig_patent_app_number] => 11658748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9299404 [patent_doc_number] => 08647625 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-11 [patent_title] => 'Anti-CD154 antibodies' [patent_app_type] => utility [patent_app_number] => 11/572647 [patent_app_country] => US [patent_app_date] => 2005-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42149 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11572647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5766793 [patent_doc_number] => 20060018907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Anti-TNF antibodies and peptides of human tumor necrosis factor' [patent_app_type] => utility [patent_app_number] => 11/182033 [patent_app_country] => US [patent_app_date] => 2005-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 66812 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018907.pdf [firstpage_image] =>[orig_patent_app_number] => 11182033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 626796 [patent_doc_number] => 07135179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-14 [patent_title] => 'Methods for treating sarcoidosis using anti-TNF antibodies and fragments thereof' [patent_app_type] => utility [patent_app_number] => 11/181030 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 49 [patent_no_of_words] => 52072 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/135/07135179.pdf [firstpage_image] =>[orig_patent_app_number] => 11181030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 633853 [patent_doc_number] => 07128908 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-31 [patent_title] => 'Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof' [patent_app_type] => utility [patent_app_number] => 11/179359 [patent_app_country] => US [patent_app_date] => 2005-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 49 [patent_no_of_words] => 52104 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/128/07128908.pdf [firstpage_image] =>[orig_patent_app_number] => 11179359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5688914 [patent_doc_number] => 20060287229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Novel CD40 variants' [patent_app_type] => utility [patent_app_number] => 11/172493 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 38868 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287229.pdf [firstpage_image] =>[orig_patent_app_number] => 11172493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793135 [patent_doc_number] => 20060013816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Method of treating psoriasis using human anti-TNF antibodies and fragments' [patent_app_type] => utility [patent_app_number] => 11/170753 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 51758 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20060013816.pdf [firstpage_image] =>[orig_patent_app_number] => 11170753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793127 [patent_doc_number] => 20060013808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Treatment for asthma' [patent_app_type] => utility [patent_app_number] => 11/169171 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10217 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20060013808.pdf [firstpage_image] =>[orig_patent_app_number] => 11169171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5912859 [patent_doc_number] => 20060127921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'PECAM-1-related molecules compositions kit of parts and associated methods of use' [patent_app_type] => utility [patent_app_number] => 11/158447 [patent_app_country] => US [patent_app_date] => 2005-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7102 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127921.pdf [firstpage_image] =>[orig_patent_app_number] => 11158447 [rel_patent_id] =>[rel_patent_doc_number] =>)